data_1v3a_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1v3a _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.904 0.383 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.72 -60.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.553 1.141 . . . . 0.0 112.19 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -69.5 2.83 2.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.786 2.034 . . . . 0.0 114.331 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttt -61.56 112.33 2.17 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.165 1.786 . . . . 0.0 112.181 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -120.79 -12.11 8.88 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.925 1.29 . . . . 0.0 113.678 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 ttp-105 -64.92 -52.77 47.42 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.146 1.378 . . . . 0.0 114.185 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.13 126.83 11.48 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.358 2.039 . . . . 0.0 111.401 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.0 160.54 30.72 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.704 1.202 . . . . 0.0 112.931 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.19 173.19 13.39 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.947 3.098 . . . . 0.0 112.2 169.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.0 t -116.33 124.48 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.651 1.58 . . . . 0.0 110.124 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -93.45 115.18 27.7 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.361 1.464 . . . . 0.0 110.509 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.99 105.02 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 120.941 -1.099 . . . . 0.0 110.12 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.5 t -95.43 98.51 10.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.166 0.986 . . . . 0.0 110.587 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.27 165.06 19.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.978 1.711 . . . . 0.0 111.537 171.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -55.58 -27.36 48.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.702 1.201 . . . . 0.0 113.072 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -84.88 -38.83 18.97 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.518 1.927 . . . . 0.0 113.742 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -175.17 -169.98 0.42 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.749 1.62 . . . . 0.0 113.873 -169.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -130.76 126.25 35.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.555 1.142 . . . . 0.0 113.477 169.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PHE . . . . . 0.415 ' CE1' HG12 ' A' ' 88' ' ' VAL . 3.6 m-85 -120.12 127.54 52.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.039 0.936 . . . . 0.0 109.819 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.34 140.77 31.37 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.527 -1.358 . . . . 0.0 111.075 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.77 126.42 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.529 1.532 . . . . 0.0 111.121 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m -122.24 120.18 33.37 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.393 1.477 . . . . 0.0 111.916 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -178.26 1.88 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.956 1.303 . . . . 0.0 111.989 169.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.0 m120 64.09 166.01 0.11 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 127.345 2.258 . . . . 0.0 113.093 -171.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.88 -168.22 0.35 Allowed 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.628 2.886 . . . . 0.0 112.733 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.1 p -114.86 -146.15 0.4 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 127.623 2.369 . . . . 0.0 110.684 170.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 52.31 -78.47 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 129.415 3.086 . . . . 0.0 114.5 -169.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -32.55 73.71 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.892 1.277 . . . . 0.0 113.58 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.0 p -99.16 -13.41 19.78 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.487 1.915 . . . . 0.0 112.914 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.5 tp -55.58 -38.8 69.85 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.66 1.184 . . . . 0.0 112.316 -174.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 m -54.07 -16.87 2.2 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.251 2.221 . . . . 0.0 114.648 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -112.0 -36.07 5.49 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.595 1.958 . . . . 0.0 112.357 171.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -47.68 -52.66 17.46 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.839 1.255 . . . . 0.0 112.166 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.1 mt -58.08 -45.05 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.852 1.261 . . . . 0.0 111.196 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.56 -20.26 65.37 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.55 -57.85 3.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.336 1.454 . . . . 0.0 109.398 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.53 -42.85 67.87 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.336 -0.853 . . . . 0.0 112.868 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -21.41 63.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.872 0.76 . . . . 0.0 112.714 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -74.52 -44.14 52.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.668 1.987 . . . . 0.0 112.124 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -73.61 -3.97 31.26 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.58 11.34 84.18 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.391 0.996 . . . . 0.0 113.344 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.05 69.66 3.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.05 1.34 . . . . 0.0 111.048 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.7 p -78.37 6.86 7.46 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.064 1.746 . . . . 0.0 113.234 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.7 m -127.52 130.32 48.94 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.985 2.114 . . . . 0.0 107.852 169.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.92 130.64 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.27 1.428 . . . . 0.0 110.878 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.0 t -130.82 123.18 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.775 0.83 . . . . 0.0 110.249 -172.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -123.91 120.01 31.29 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.958 1.303 . . . . 0.0 111.658 -174.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.55 -24.15 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 127.893 2.477 . . . . 0.0 115.722 -169.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.54 -66.65 0.86 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.527 1.058 . . . . 0.0 113.079 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -155.94 133.44 10.95 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.054 1.742 . . . . 0.0 107.874 171.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.85 140.65 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.587 1.085 . . . . 0.0 111.32 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.0 p -132.93 3.73 3.77 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -139.37 168.52 19.63 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.475 1.11 . . . . 0.0 112.773 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -110.55 118.45 36.28 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.098 1.359 . . . . 0.0 111.304 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.61 102.57 4.61 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.286 1.834 . . . . 0.0 113.91 -175.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . 0.322 0.1 OUTLIER -139.51 -72.14 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.721 1.609 . . . . 0.0 112.722 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.4 -48.29 14.01 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.928 3.085 . . . . 0.0 111.424 -175.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -68.61 -32.85 73.03 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.78 -48.47 66.23 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.211 -0.93 . . . . 0.0 109.821 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -71.68 -7.58 48.85 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.612 1.165 . . . . 0.0 113.705 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -84.32 -12.77 54.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.526 1.53 . . . . 0.0 112.509 169.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.53 14.95 4.2 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.861 1.696 . . . . 0.0 115.774 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.3 mt -102.84 131.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.457 1.628 . . . . 0.0 111.868 -172.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.4 m -80.38 107.44 13.19 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.202 0.601 . . . . 0.0 109.906 171.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 24.8 t -96.37 129.65 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.697 1.199 . . . . 0.0 110.841 175.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.0 t -122.22 107.97 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.476 1.51 . . . . 0.0 109.428 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -110.44 79.78 1.24 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.526 2.73 . . . . 0.0 111.082 -170.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -71.62 -62.34 1.74 Allowed Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -81.51 60.64 7.75 Favored 'Trans proline' 0 CA--C 1.543 0.974 1 C-N-CA 125.673 4.249 . . . . 0.0 113.55 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -96.39 -40.8 8.93 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.194 -0.941 . . . . 0.0 112.807 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -163.65 -179.97 6.78 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.795 1.638 . . . . 0.0 110.649 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.9 -9.05 3.62 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.5 1.52 . . . . 0.0 114.082 170.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.49 -17.82 71.09 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.56 1.076 . . . . 0.0 113.721 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.23 151.49 40.43 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.302 1.441 . . . . 0.0 111.486 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.63 166.81 28.27 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.852 3.035 . . . . 0.0 112.999 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.99 165.98 26.31 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.127 2.551 . . . . 0.0 111.583 170.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.79 -2.07 4.93 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.689 2.926 . . . . 0.0 114.934 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.67 -49.54 36.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.709 1.623 . . . . 0.0 114.637 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.85 -23.85 26.95 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.515 1.657 . . . . 0.0 114.505 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 82.4 t -56.0 -19.3 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.684 1.594 . . . . 0.0 112.027 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 34.2 m -48.15 -51.32 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.385 1.874 . . . . 0.0 115.021 170.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -38.43 87.34 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.504 -1.372 . . . . 0.0 111.708 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -41.27 79.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.639 2.376 . . . . 0.0 110.778 169.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . 0.462 ' HE1' ' HA ' ' A' ' 114' ' ' LEU . 0.6 OUTLIER -58.13 -63.68 1.18 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.181 1.793 . . . . 0.0 109.888 172.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -61.46 -48.23 82.1 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.39 1.45 . . . . 0.0 110.826 -172.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.8 t -56.44 -38.2 71.28 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 8.2 tp -61.39 -65.9 0.62 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.685 1.13 . . . . 0.0 109.831 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.415 HG12 ' CE1' ' A' ' 19' ' ' PHE . 15.8 t -62.06 -25.79 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.802 0.728 . . . . 0.0 111.257 -169.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -66.09 -53.97 31.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.809 2.043 . . . . 0.0 110.414 169.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.7 -39.04 70.44 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 11.1 mmpt? -64.5 -15.37 60.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.555 1.142 . . . . 0.0 113.597 178.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -108.44 -9.35 15.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.519 2.328 . . . . 0.0 112.692 172.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.3 t -86.91 -40.28 14.98 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.934 1.294 . . . . 0.0 111.886 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -59.54 -23.26 62.71 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.856 1.663 . . . . 0.0 115.145 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.34 168.29 17.79 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 129.351 3.06 . . . . 0.0 111.093 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.08 10.47 1.42 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.952 3.101 . . . . 0.0 116.09 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.99 -65.99 0.15 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 127.497 2.475 . . . . 0.0 111.632 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 t 52.57 -165.92 0.06 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.64 1.576 . . . . 0.0 113.291 -173.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.25 155.11 46.05 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.77 2.028 . . . . 0.0 110.784 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.76 119.44 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.264 0.626 . . . . 0.0 111.931 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.96 136.66 32.87 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.875 -1.141 . . . . 0.0 111.315 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.41 141.51 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.819 0.819 . . . . 0.0 111.973 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -133.78 155.04 50.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.973 1.709 . . . . 0.0 110.93 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 27.3 p -149.83 160.97 43.15 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.574 1.55 . . . . 0.0 112.288 173.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.91 108.49 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.989 0.916 . . . . 0.0 109.938 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.89 130.44 45.84 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.761 1.224 . . . . 0.0 111.879 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -177.72 -69.44 0.06 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.999 0.809 . . . . 0.0 112.937 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.9 tt -143.37 96.19 2.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.058 1.343 . . . . 0.0 110.31 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.06 179.16 44.41 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.233 1.397 . . . . 0.0 113.775 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.1 ttm105 -127.09 50.63 1.96 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.893 1.677 . . . . 0.0 112.323 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 36.46 55.09 2.89 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 127.162 2.185 . . . . 0.0 114.474 -171.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.91 -14.55 41.62 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.333 2.689 . . . . 0.0 112.999 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -50.85 -31.12 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.095 1.758 . . . . 0.0 111.775 169.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.462 ' HA ' ' HE1' ' A' ' 84' ' ' TRP . 6.2 tp -63.83 -76.66 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 171.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.8 t -53.34 -46.95 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.188 -0.945 . . . . 0.0 112.387 -169.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -45.82 -36.12 4.97 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.215 1.406 . . . . 0.0 113.704 174.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -55.03 -50.23 69.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.317 -0.864 . . . . 0.0 111.482 177.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.73 -37.67 87.45 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.76 -0.587 . . . . 0.0 112.031 174.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 22.4 tp -53.98 -43.84 70.31 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.806 1.242 . . . . 0.0 111.998 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.8 mp -73.28 -48.87 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 121.135 -0.978 . . . . 0.0 110.378 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -62.58 -21.6 65.73 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.2 p -71.1 -17.28 62.59 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 169.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.07 -6.38 3.7 Favored Glycine 0 CA--C 1.541 1.704 0 C-N-CA 126.85 2.167 . . . . 0.0 116.102 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.5 tpp -71.29 166.59 21.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.821 1.811 . . . . 0.0 112.627 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.12 135.65 45.22 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.422 1.889 . . . . 0.0 107.405 169.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -58.81 -33.82 70.81 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -58.05 -35.98 72.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.261 1.424 . . . . 0.0 113.084 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.86 -45.68 41.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.499 1.12 . . . . 0.0 111.14 170.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.64 61.56 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.939 1.296 . . . . 0.0 113.559 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.5 mm -51.48 -55.99 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.479 1.036 . . . . 0.0 110.043 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -61.62 -17.45 55.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.313 1.445 . . . . 0.0 112.802 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -85.74 -51.94 6.1 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.985 1.714 . . . . 0.0 112.565 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ILE . . . . . . . . . . . . . 2.0 pt -84.85 -44.23 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -14.14 7.58 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.448 1.899 . . . . 0.0 112.987 175.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -53.87 -18.57 3.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.307 1.443 . . . . 0.0 114.37 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -16.83 63.97 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.428 1.491 . . . . 0.0 113.146 172.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 100.92 104.0 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 1 C-N-CA 132.804 4.442 . . . . 0.0 110.115 173.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 59.87 -170.85 0.13 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 127.106 2.162 . . . . 0.0 112.546 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.08 2.3 68.94 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.07 52.14 1.15 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.921 1.288 . . . . 0.0 112.383 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.2 tt -142.08 16.91 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.27 172.68 6.63 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.786 1.234 . . . . 0.0 112.906 173.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.3 t -73.63 -89.06 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.233 1.013 . . . . 0.0 112.278 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -56.49 -23.82 41.86 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.703 1.601 . . . . 0.0 114.409 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -53.72 -47.95 70.06 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.14 1.776 . . . . 0.0 112.798 169.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.44 -33.82 7.6 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.239 0.927 . . . . 0.0 113.399 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.6 p -65.06 -3.74 3.98 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -53.41 -40.08 64.82 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.34 -32.47 68.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.121 1.768 . . . . 0.0 113.023 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.63 -11.44 7.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.324 1.45 . . . . 0.0 112.248 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -121.63 -33.93 3.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.552 2.341 . . . . 0.0 113.667 170.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -99.08 116.75 32.01 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.48 1.512 . . . . 0.0 113.753 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -69.95 129.14 91.21 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.431 1.093 . . . . 0.0 112.784 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.06 3.18 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.786 2.99 . . . . 0.0 114.708 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.87 160.07 15.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.431 1.492 . . . . 0.0 111.522 174.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 87.39 12.05 0.12 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 129.031 2.932 . . . . 0.0 113.691 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.25 -92.6 0.54 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.2 1.4 . . . . 0.0 111.786 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.6 mt -87.25 47.45 1.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.217 1.007 . . . . 0.0 112.609 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -131.34 -76.8 0.52 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.503 1.921 . . . . 0.0 111.288 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -147.54 99.92 3.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.441 1.496 . . . . 0.0 110.489 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -147.95 -42.59 0.16 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.854 1.262 . . . . 0.0 113.33 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.313 1.845 . . . . 0.0 113.345 -170.484 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.904 0.383 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.72 -60.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.553 1.141 . . . . 0.0 112.19 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -69.5 2.83 2.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.786 2.034 . . . . 0.0 114.331 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttt -61.56 112.33 2.17 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.165 1.786 . . . . 0.0 112.181 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -120.79 -12.11 8.88 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.925 1.29 . . . . 0.0 113.678 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 ttp-105 -64.92 -52.77 47.42 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.146 1.378 . . . . 0.0 114.185 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.13 126.83 11.48 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.358 2.039 . . . . 0.0 111.401 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.0 160.54 30.72 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.704 1.202 . . . . 0.0 112.931 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.19 173.19 13.39 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.947 3.098 . . . . 0.0 112.2 169.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.0 t -116.33 124.48 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.651 1.58 . . . . 0.0 110.124 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -93.45 115.18 27.7 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.361 1.464 . . . . 0.0 110.509 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.99 105.02 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 120.941 -1.099 . . . . 0.0 110.12 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.5 t -95.43 98.51 10.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.166 0.986 . . . . 0.0 110.587 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.27 165.06 19.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.978 1.711 . . . . 0.0 111.537 171.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -55.58 -27.36 48.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.702 1.201 . . . . 0.0 113.072 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -84.88 -38.83 18.97 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.518 1.927 . . . . 0.0 113.742 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . 0.426 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -175.17 -169.98 0.42 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.749 1.62 . . . . 0.0 113.873 -169.81 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -130.76 126.25 35.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.555 1.142 . . . . 0.0 113.477 169.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' CE1' HG13 ' A' ' 88' ' ' VAL . 3.6 m-85 -120.12 127.54 52.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.039 0.936 . . . . 0.0 109.819 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.34 140.77 31.37 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.527 -1.358 . . . . 0.0 111.075 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.77 126.42 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.529 1.532 . . . . 0.0 111.121 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m -122.24 120.18 33.37 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.393 1.477 . . . . 0.0 111.916 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -178.26 1.88 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.956 1.303 . . . . 0.0 111.989 169.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.0 m120 64.09 166.01 0.11 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 127.345 2.258 . . . . 0.0 113.093 -171.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.88 -168.22 0.35 Allowed 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.628 2.886 . . . . 0.0 112.733 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 27' ' ' ASN . 13.1 p -114.86 -146.15 0.4 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 127.623 2.369 . . . . 0.0 110.684 170.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' H ' ' HB ' ' A' ' 26' ' ' THR . 13.9 t-20 52.31 -78.47 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 129.415 3.086 . . . . 0.0 114.5 -169.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -32.55 73.71 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.892 1.277 . . . . 0.0 113.58 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.0 p -99.16 -13.41 19.78 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.487 1.915 . . . . 0.0 112.914 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.5 tp -55.58 -38.8 69.85 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.66 1.184 . . . . 0.0 112.316 -174.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 m -54.07 -16.87 2.2 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.251 2.221 . . . . 0.0 114.648 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -112.0 -36.07 5.49 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.595 1.958 . . . . 0.0 112.357 171.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -47.68 -52.66 17.46 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.839 1.255 . . . . 0.0 112.166 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.1 mt -58.08 -45.05 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.852 1.261 . . . . 0.0 111.196 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.56 -20.26 65.37 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.55 -57.85 3.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.336 1.454 . . . . 0.0 109.398 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.53 -42.85 67.87 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.336 -0.853 . . . . 0.0 112.868 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -21.41 63.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.872 0.76 . . . . 0.0 112.714 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -74.52 -44.14 52.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.668 1.987 . . . . 0.0 112.124 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -73.61 -3.97 31.26 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.58 11.34 84.18 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.391 0.996 . . . . 0.0 113.344 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.05 69.66 3.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.05 1.34 . . . . 0.0 111.048 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.7 p -78.37 6.86 7.46 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.064 1.746 . . . . 0.0 113.234 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.475 HG21 ' CD ' ' A' ' 91' ' ' LYS . 54.7 m -127.52 130.32 48.94 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.985 2.114 . . . . 0.0 107.852 169.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.92 130.64 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.27 1.428 . . . . 0.0 110.878 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 87' ' ' LEU . 48.0 t -130.82 123.18 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.775 0.83 . . . . 0.0 110.249 -172.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -123.91 120.01 31.29 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.958 1.303 . . . . 0.0 111.658 -174.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.55 -24.15 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 127.893 2.477 . . . . 0.0 115.722 -169.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.54 -66.65 0.86 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.527 1.058 . . . . 0.0 113.079 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -155.94 133.44 10.95 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.054 1.742 . . . . 0.0 107.874 171.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.85 140.65 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.587 1.085 . . . . 0.0 111.32 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.0 p -132.93 3.73 3.77 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -139.37 168.52 19.63 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.475 1.11 . . . . 0.0 112.773 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -110.55 118.45 36.28 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.098 1.359 . . . . 0.0 111.304 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HB3' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -74.61 102.57 4.61 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.286 1.834 . . . . 0.0 113.91 -175.554 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.414 HG23 ' CD ' ' A' ' 57' ' ' PRO 0.322 0.1 OUTLIER -139.51 -72.14 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.721 1.609 . . . . 0.0 112.722 -179.676 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' CD ' HG23 ' A' ' 56' ' ' THR . 18.7 Cg_endo -59.4 -48.29 14.01 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.928 3.085 . . . . 0.0 111.424 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.529 HD21 HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -68.61 -32.85 73.03 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.78 -48.47 66.23 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.211 -0.93 . . . . 0.0 109.821 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -71.68 -7.58 48.85 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.612 1.165 . . . . 0.0 113.705 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -84.32 -12.77 54.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.526 1.53 . . . . 0.0 112.509 169.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.53 14.95 4.2 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.861 1.696 . . . . 0.0 115.774 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.3 mt -102.84 131.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.457 1.628 . . . . 0.0 111.868 -172.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.4 m -80.38 107.44 13.19 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.202 0.601 . . . . 0.0 109.906 171.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.529 HG22 HD21 ' A' ' 58' ' ' LEU . 24.8 t -96.37 129.65 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.697 1.199 . . . . 0.0 110.841 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.0 t -122.22 107.97 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.476 1.51 . . . . 0.0 109.428 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -110.44 79.78 1.24 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.526 2.73 . . . . 0.0 111.082 -170.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -71.62 -62.34 1.74 Allowed Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -81.51 60.64 7.75 Favored 'Trans proline' 0 CA--C 1.543 0.974 1 C-N-CA 125.673 4.249 . . . . 0.0 113.55 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -96.39 -40.8 8.93 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.194 -0.941 . . . . 0.0 112.807 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -163.65 -179.97 6.78 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.795 1.638 . . . . 0.0 110.649 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.9 -9.05 3.62 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.5 1.52 . . . . 0.0 114.082 170.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.49 -17.82 71.09 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.56 1.076 . . . . 0.0 113.721 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.23 151.49 40.43 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.302 1.441 . . . . 0.0 111.486 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.63 166.81 28.27 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.852 3.035 . . . . 0.0 112.999 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.99 165.98 26.31 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.127 2.551 . . . . 0.0 111.583 170.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.79 -2.07 4.93 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.689 2.926 . . . . 0.0 114.934 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.67 -49.54 36.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.709 1.623 . . . . 0.0 114.637 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.85 -23.85 26.95 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.515 1.657 . . . . 0.0 114.505 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 82.4 t -56.0 -19.3 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.684 1.594 . . . . 0.0 112.027 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.505 HG12 HD21 ' A' ' 117' ' ' LEU . 34.2 m -48.15 -51.32 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.385 1.874 . . . . 0.0 115.021 170.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -38.43 87.34 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.504 -1.372 . . . . 0.0 111.708 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -41.27 79.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.639 2.376 . . . . 0.0 110.778 169.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . 0.726 ' CH2' ' HB2' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -58.13 -63.68 1.18 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.181 1.793 . . . . 0.0 109.888 172.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.4 HD21 ' HG3' ' A' ' 121' ' ' GLU . 3.4 mm? -61.46 -48.23 82.1 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.39 1.45 . . . . 0.0 110.826 -172.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.8 t -56.44 -38.2 71.28 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD21 HG21 ' A' ' 46' ' ' VAL . 8.2 tp -61.39 -65.9 0.62 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.685 1.13 . . . . 0.0 109.831 170.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.698 HG13 ' CE1' ' A' ' 19' ' ' PHE . 15.8 t -62.06 -25.79 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.802 0.728 . . . . 0.0 111.257 -169.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -66.09 -53.97 31.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.809 2.043 . . . . 0.0 110.414 169.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.7 -39.04 70.44 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.475 ' CD ' HG21 ' A' ' 44' ' ' THR . 11.1 mmpt? -64.5 -15.37 60.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.555 1.142 . . . . 0.0 113.597 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -108.44 -9.35 15.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.519 2.328 . . . . 0.0 112.692 172.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.3 t -86.91 -40.28 14.98 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.934 1.294 . . . . 0.0 111.886 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -59.54 -23.26 62.71 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.856 1.663 . . . . 0.0 115.145 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.34 168.29 17.79 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 129.351 3.06 . . . . 0.0 111.093 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.08 10.47 1.42 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.952 3.101 . . . . 0.0 116.09 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.99 -65.99 0.15 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 127.497 2.475 . . . . 0.0 111.632 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 t 52.57 -165.92 0.06 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.64 1.576 . . . . 0.0 113.291 -173.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.25 155.11 46.05 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.77 2.028 . . . . 0.0 110.784 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.76 119.44 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.264 0.626 . . . . 0.0 111.931 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.96 136.66 32.87 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.875 -1.141 . . . . 0.0 111.315 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.41 141.51 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.819 0.819 . . . . 0.0 111.973 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -133.78 155.04 50.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.973 1.709 . . . . 0.0 110.93 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 27.3 p -149.83 160.97 43.15 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.574 1.55 . . . . 0.0 112.288 173.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.91 108.49 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.989 0.916 . . . . 0.0 109.938 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.89 130.44 45.84 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.761 1.224 . . . . 0.0 111.879 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -177.72 -69.44 0.06 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.999 0.809 . . . . 0.0 112.937 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.9 tt -143.37 96.19 2.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.058 1.343 . . . . 0.0 110.31 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.06 179.16 44.41 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.233 1.397 . . . . 0.0 113.775 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.1 ttm105 -127.09 50.63 1.96 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.893 1.677 . . . . 0.0 112.323 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 36.46 55.09 2.89 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 127.162 2.185 . . . . 0.0 114.474 -171.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.91 -14.55 41.62 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.333 2.689 . . . . 0.0 112.999 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -50.85 -31.12 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.095 1.758 . . . . 0.0 111.775 169.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.554 ' HA ' ' HE1' ' A' ' 84' ' ' TRP . 6.2 tp -63.83 -76.66 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 171.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.8 t -53.34 -46.95 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.188 -0.945 . . . . 0.0 112.387 -169.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 133' ' ' ILE . . . -45.82 -36.12 4.97 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.215 1.406 . . . . 0.0 113.704 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -55.03 -50.23 69.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.317 -0.864 . . . . 0.0 111.482 177.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.726 ' HB2' ' CH2' ' A' ' 84' ' ' TRP . . . -62.73 -37.67 87.45 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.76 -0.587 . . . . 0.0 112.031 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 22.4 tp -53.98 -43.84 70.31 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.806 1.242 . . . . 0.0 111.998 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 126' ' ' TYR . 1.8 mp -73.28 -48.87 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 121.135 -0.978 . . . . 0.0 110.378 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HG3' HD21 ' A' ' 85' ' ' LEU . 65.4 mm-40 -62.58 -21.6 65.73 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.2 p -71.1 -17.28 62.59 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 169.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.07 -6.38 3.7 Favored Glycine 0 CA--C 1.541 1.704 0 C-N-CA 126.85 2.167 . . . . 0.0 116.102 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.5 tpp -71.29 166.59 21.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.821 1.811 . . . . 0.0 112.627 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.12 135.65 45.22 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.422 1.889 . . . . 0.0 107.405 169.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.45 ' HA ' HD11 ' A' ' 120' ' ' ILE . 3.7 p90 -58.81 -33.82 70.81 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -58.05 -35.98 72.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.261 1.424 . . . . 0.0 113.084 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.86 -45.68 41.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.499 1.12 . . . . 0.0 111.14 170.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.64 61.56 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.939 1.296 . . . . 0.0 113.559 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.5 mm -51.48 -55.99 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.479 1.036 . . . . 0.0 110.043 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -61.62 -17.45 55.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.313 1.445 . . . . 0.0 112.802 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -85.74 -51.94 6.1 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.985 1.714 . . . . 0.0 112.565 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 116' ' ' ALA . 2.0 pt -84.85 -44.23 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -14.14 7.58 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.448 1.899 . . . . 0.0 112.987 175.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -53.87 -18.57 3.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.307 1.443 . . . . 0.0 114.37 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -16.83 63.97 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.428 1.491 . . . . 0.0 113.146 172.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 100.92 104.0 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 1 C-N-CA 132.804 4.442 . . . . 0.0 110.115 173.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 59.87 -170.85 0.13 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 127.106 2.162 . . . . 0.0 112.546 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.08 2.3 68.94 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.07 52.14 1.15 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.921 1.288 . . . . 0.0 112.383 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.2 tt -142.08 16.91 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.27 172.68 6.63 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.786 1.234 . . . . 0.0 112.906 173.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.3 t -73.63 -89.06 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.233 1.013 . . . . 0.0 112.278 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -56.49 -23.82 41.86 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.703 1.601 . . . . 0.0 114.409 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -53.72 -47.95 70.06 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.14 1.776 . . . . 0.0 112.798 169.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.44 -33.82 7.6 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.239 0.927 . . . . 0.0 113.399 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.6 p -65.06 -3.74 3.98 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -53.41 -40.08 64.82 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.34 -32.47 68.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.121 1.768 . . . . 0.0 113.023 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.63 -11.44 7.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.324 1.45 . . . . 0.0 112.248 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -121.63 -33.93 3.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.552 2.341 . . . . 0.0 113.667 170.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -99.08 116.75 32.01 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.48 1.512 . . . . 0.0 113.753 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -69.95 129.14 91.21 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.431 1.093 . . . . 0.0 112.784 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.06 3.18 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.786 2.99 . . . . 0.0 114.708 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.87 160.07 15.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.431 1.492 . . . . 0.0 111.522 174.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 87.39 12.05 0.12 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 129.031 2.932 . . . . 0.0 113.691 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.25 -92.6 0.54 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.2 1.4 . . . . 0.0 111.786 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.6 mt -87.25 47.45 1.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.217 1.007 . . . . 0.0 112.609 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -131.34 -76.8 0.52 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.503 1.921 . . . . 0.0 111.288 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -147.54 99.92 3.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.441 1.496 . . . . 0.0 110.489 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -147.95 -42.59 0.16 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.854 1.262 . . . . 0.0 113.33 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.313 1.845 . . . . 0.0 113.345 -170.484 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.4 ttp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.904 0.383 . . . . 0.0 111.08 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.72 -60.93 0.17 Allowed 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 124.553 1.141 . . . . 0.0 112.19 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.7 tmm_? -69.5 2.83 2.76 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 126.786 2.034 . . . . 0.0 114.331 174.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.4 ttt -61.56 112.33 2.17 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.165 1.786 . . . . 0.0 112.181 -177.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 38.1 t30 -120.79 -12.11 8.88 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.925 1.29 . . . . 0.0 113.678 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.2 ttp-105 -64.92 -52.77 47.42 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.146 1.378 . . . . 0.0 114.185 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -73.13 126.83 11.48 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 122.358 2.039 . . . . 0.0 111.401 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -95.0 160.54 30.72 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.704 1.202 . . . . 0.0 112.931 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -72.19 173.19 13.39 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.947 3.098 . . . . 0.0 112.2 169.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 79.0 t -116.33 124.48 72.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.651 1.58 . . . . 0.0 110.124 -178.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -93.45 115.18 27.7 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.361 1.464 . . . . 0.0 110.509 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 5.4 p -98.99 105.02 16.75 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 O-C-N 120.941 -1.099 . . . . 0.0 110.12 177.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 40.5 t -95.43 98.51 10.61 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.166 0.986 . . . . 0.0 110.587 178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -83.27 165.06 19.68 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.978 1.711 . . . . 0.0 111.537 171.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -55.58 -27.36 48.8 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.702 1.201 . . . . 0.0 113.072 169.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' HIS . . . . . . . . . . . . . 75.0 m-70 -84.88 -38.83 18.97 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 126.518 1.927 . . . . 0.0 113.742 -178.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . 0.426 ' HG2' ' CG1' ' A' ' 88' ' ' VAL . 0.0 OUTLIER -175.17 -169.98 0.42 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 125.749 1.62 . . . . 0.0 113.873 -169.81 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.0 ttt180 -130.76 126.25 35.9 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.555 1.142 . . . . 0.0 113.477 169.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PHE . . . . . 0.698 ' CE1' HG13 ' A' ' 88' ' ' VAL . 3.6 m-85 -120.12 127.54 52.62 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.039 0.936 . . . . 0.0 109.819 -177.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -84.34 140.77 31.37 Favored 'General case' 0 CA--C 1.535 0.384 0 O-C-N 120.527 -1.358 . . . . 0.0 111.075 170.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.77 126.42 66.83 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 C-N-CA 125.529 1.532 . . . . 0.0 111.121 177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 m -122.24 120.18 33.37 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 125.393 1.477 . . . . 0.0 111.916 -175.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -178.26 1.88 Allowed 'General case' 0 CA--C 1.553 1.096 0 C-N-CA 124.956 1.303 . . . . 0.0 111.989 169.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.0 m120 64.09 166.01 0.11 Allowed Pre-proline 0 CA--C 1.558 1.259 0 C-N-CA 127.345 2.258 . . . . 0.0 113.093 -171.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.88 -168.22 0.35 Allowed 'Trans proline' 0 CA--C 1.548 1.207 0 C-N-CA 123.628 2.886 . . . . 0.0 112.733 174.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.402 ' HB ' ' H ' ' A' ' 27' ' ' ASN . 13.1 p -114.86 -146.15 0.4 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 127.623 2.369 . . . . 0.0 110.684 170.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.402 ' H ' ' HB ' ' A' ' 26' ' ' THR . 13.9 t-20 52.31 -78.47 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 129.415 3.086 . . . . 0.0 114.5 -169.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -62.75 -32.55 73.71 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.892 1.277 . . . . 0.0 113.58 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 46.0 p -99.16 -13.41 19.78 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.487 1.915 . . . . 0.0 112.914 178.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 49.5 tp -55.58 -38.8 69.85 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 124.66 1.184 . . . . 0.0 112.316 -174.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 m -54.07 -16.87 2.2 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.251 2.221 . . . . 0.0 114.648 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 90.1 m -112.0 -36.07 5.49 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 126.595 1.958 . . . . 0.0 112.357 171.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -47.68 -52.66 17.46 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.839 1.255 . . . . 0.0 112.166 175.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 42.1 mt -58.08 -45.05 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 124.852 1.261 . . . . 0.0 111.196 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -67.56 -20.26 65.37 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.55 -57.85 3.16 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.336 1.454 . . . . 0.0 109.398 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 pp -53.53 -42.85 67.87 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.336 -0.853 . . . . 0.0 112.868 178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.86 -21.41 63.34 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-N 118.872 0.76 . . . . 0.0 112.714 -178.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -74.52 -44.14 52.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 126.668 1.987 . . . . 0.0 112.124 170.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 45.8 m-85 -73.61 -3.97 31.26 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 175.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 80.58 11.34 84.18 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.391 0.996 . . . . 0.0 113.344 -177.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -77.05 69.66 3.36 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.05 1.34 . . . . 0.0 111.048 173.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 29.7 p -78.37 6.86 7.46 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 126.064 1.746 . . . . 0.0 113.234 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.475 HG21 ' CD ' ' A' ' 91' ' ' LYS . 54.7 m -127.52 130.32 48.94 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.985 2.114 . . . . 0.0 107.852 169.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 6.3 m -120.92 130.64 74.44 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 125.27 1.428 . . . . 0.0 110.878 175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 87' ' ' LEU . 48.0 t -130.82 123.18 53.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.775 0.83 . . . . 0.0 110.249 -172.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 44.7 ttt180 -123.91 120.01 31.29 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.958 1.303 . . . . 0.0 111.658 -174.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.1 p -119.55 -24.15 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 127.893 2.477 . . . . 0.0 115.722 -169.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . . . . . . . . . 48.1 t -80.54 -66.65 0.86 Allowed 'General case' 0 CA--C 1.546 0.82 0 CA-C-N 119.527 1.058 . . . . 0.0 113.079 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -155.94 133.44 10.95 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 126.054 1.742 . . . . 0.0 107.874 171.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 16.9 m -93.85 140.65 16.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-N 119.587 1.085 . . . . 0.0 111.32 176.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 67.0 p -132.93 3.73 3.77 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 115.253 1.575 . . . . 0.0 115.253 -173.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -139.37 168.52 19.63 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.475 1.11 . . . . 0.0 112.773 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -110.55 118.45 36.28 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.098 1.359 . . . . 0.0 111.304 -177.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.43 ' HB3' HG11 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -74.61 102.57 4.61 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.286 1.834 . . . . 0.0 113.91 -175.554 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.414 HG23 ' CD ' ' A' ' 57' ' ' PRO 0.322 0.1 OUTLIER -139.51 -72.14 0.02 OUTLIER Pre-proline 0 N--CA 1.478 0.944 0 C-N-CA 125.721 1.609 . . . . 0.0 112.722 -179.676 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.414 ' CD ' HG23 ' A' ' 56' ' ' THR . 18.7 Cg_endo -59.4 -48.29 14.01 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 123.928 3.085 . . . . 0.0 111.424 -175.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.529 HD21 HG22 ' A' ' 65' ' ' VAL . 0.0 OUTLIER -68.61 -32.85 73.03 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.78 -48.47 66.23 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.211 -0.93 . . . . 0.0 109.821 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -71.68 -7.58 48.85 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 124.612 1.165 . . . . 0.0 113.705 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -84.32 -12.77 54.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.526 1.53 . . . . 0.0 112.509 169.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 122.53 14.95 4.2 Favored Glycine 0 CA--C 1.537 1.43 0 C-N-CA 125.861 1.696 . . . . 0.0 115.774 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 75.3 mt -102.84 131.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 119.457 1.628 . . . . 0.0 111.868 -172.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 97.4 m -80.38 107.44 13.19 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 123.202 0.601 . . . . 0.0 109.906 171.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.529 HG22 HD21 ' A' ' 58' ' ' LEU . 24.8 t -96.37 129.65 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.697 1.199 . . . . 0.0 110.841 175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 6.0 t -122.22 107.97 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 C-N-CA 125.476 1.51 . . . . 0.0 109.428 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -110.44 79.78 1.24 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.526 2.73 . . . . 0.0 111.082 -170.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.1 m0 -71.62 -62.34 1.74 Allowed Pre-proline 0 CA--C 1.55 0.963 0 N-CA-C 114.979 1.474 . . . . 0.0 114.979 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -81.51 60.64 7.75 Favored 'Trans proline' 0 CA--C 1.543 0.974 1 C-N-CA 125.673 4.249 . . . . 0.0 113.55 -172.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.3 p90 -96.39 -40.8 8.93 Favored 'General case' 0 N--CA 1.47 0.538 0 O-C-N 121.194 -0.941 . . . . 0.0 112.807 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -163.65 -179.97 6.78 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.795 1.638 . . . . 0.0 110.649 178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -60.9 -9.05 3.62 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.5 1.52 . . . . 0.0 114.082 170.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.49 -17.82 71.09 Favored Glycine 0 CA--C 1.54 1.602 0 C-N-CA 124.56 1.076 . . . . 0.0 113.721 169.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.23 151.49 40.43 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.302 1.441 . . . . 0.0 111.486 169.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -71.63 166.81 28.27 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.852 3.035 . . . . 0.0 112.999 176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.99 165.98 26.31 Favored 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.127 2.551 . . . . 0.0 111.583 170.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -64.79 -2.07 4.93 Favored 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 123.689 2.926 . . . . 0.0 114.934 179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -69.67 -49.54 36.16 Favored Glycine 0 CA--C 1.537 1.434 0 C-N-CA 125.709 1.623 . . . . 0.0 114.637 175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -85.85 -23.85 26.95 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.515 1.657 . . . . 0.0 114.505 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 82.4 t -56.0 -19.3 6.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.684 1.594 . . . . 0.0 112.027 -176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.505 HG12 HD21 ' A' ' 117' ' ' LEU . 34.2 m -48.15 -51.32 9.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.536 0 C-N-CA 126.385 1.874 . . . . 0.0 115.021 170.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.46 -38.43 87.34 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.504 -1.372 . . . . 0.0 111.708 -177.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.37 -41.27 79.83 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.639 2.376 . . . . 0.0 110.778 169.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . 0.726 ' CH2' ' HB2' ' A' ' 118' ' ' ALA . 0.6 OUTLIER -58.13 -63.68 1.18 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.181 1.793 . . . . 0.0 109.888 172.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.4 HD21 ' HG3' ' A' ' 121' ' ' GLU . 3.4 mm? -61.46 -48.23 82.1 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 120.39 1.45 . . . . 0.0 110.826 -172.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.8 t -56.44 -38.2 71.28 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.444 HD21 HG21 ' A' ' 46' ' ' VAL . 8.2 tp -61.39 -65.9 0.62 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.685 1.13 . . . . 0.0 109.831 170.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.698 HG13 ' CE1' ' A' ' 19' ' ' PHE . 15.8 t -62.06 -25.79 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.701 0 CA-C-N 118.802 0.728 . . . . 0.0 111.257 -169.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -66.09 -53.97 31.51 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 126.809 2.043 . . . . 0.0 110.414 169.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -71.7 -39.04 70.44 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.475 ' CD ' HG21 ' A' ' 44' ' ' THR . 11.1 mmpt? -64.5 -15.37 60.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 124.555 1.142 . . . . 0.0 113.597 178.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -108.44 -9.35 15.41 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 127.519 2.328 . . . . 0.0 112.692 172.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' CYS . . . . . . . . . . . . . 20.3 t -86.91 -40.28 14.98 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.934 1.294 . . . . 0.0 111.886 173.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -59.54 -23.26 62.71 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.856 1.663 . . . . 0.0 115.145 -176.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.34 168.29 17.79 Favored Pre-proline 0 CA--C 1.549 0.922 0 C-N-CA 129.351 3.06 . . . . 0.0 111.093 178.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -74.08 10.47 1.42 Allowed 'Trans proline' 0 CA--C 1.543 0.943 0 C-N-CA 123.952 3.101 . . . . 0.0 116.09 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 170.99 -65.99 0.15 Allowed Glycine 0 CA--C 1.529 0.919 0 C-N-CA 127.497 2.475 . . . . 0.0 111.632 176.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.3 t 52.57 -165.92 0.06 Allowed 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.64 1.576 . . . . 0.0 113.291 -173.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -141.25 155.11 46.05 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.77 2.028 . . . . 0.0 110.784 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 t -127.76 119.44 51.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.264 0.626 . . . . 0.0 111.931 171.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -87.96 136.66 32.87 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 120.875 -1.141 . . . . 0.0 111.315 177.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . . . . . . . . . 18.0 m -131.41 141.51 45.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 CA-C-O 121.819 0.819 . . . . 0.0 111.973 178.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -133.78 155.04 50.52 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.973 1.709 . . . . 0.0 110.93 -173.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' CYS . . . . . . . . . . . . . 27.3 p -149.83 160.97 43.15 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.574 1.55 . . . . 0.0 112.288 173.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 58.9 t -65.91 108.49 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 C-N-CA 123.989 0.916 . . . . 0.0 109.938 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -56.89 130.44 45.84 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 124.761 1.224 . . . . 0.0 111.879 178.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -177.72 -69.44 0.06 OUTLIER Glycine 0 CA--C 1.53 0.981 0 C-N-CA 123.999 0.809 . . . . 0.0 112.937 -178.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.9 tt -143.37 96.19 2.87 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.058 1.343 . . . . 0.0 110.31 -178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 90.06 179.16 44.41 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 125.233 1.397 . . . . 0.0 113.775 -171.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.1 ttm105 -127.09 50.63 1.96 Allowed 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 125.893 1.677 . . . . 0.0 112.323 -178.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 36.46 55.09 2.89 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 127.162 2.185 . . . . 0.0 114.474 -171.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -67.91 -14.55 41.62 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.333 2.689 . . . . 0.0 112.999 -177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.3 p -50.85 -31.12 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.095 1.758 . . . . 0.0 111.775 169.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.554 ' HA ' ' HE1' ' A' ' 84' ' ' TRP . 6.2 tp -63.83 -76.66 0.06 Allowed 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 171.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 47.8 t -53.34 -46.95 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 O-C-N 121.188 -0.945 . . . . 0.0 112.387 -169.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.614 ' HB2' HD13 ' A' ' 133' ' ' ILE . . . -45.82 -36.12 4.97 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.215 1.406 . . . . 0.0 113.704 174.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.505 HD21 HG12 ' A' ' 81' ' ' VAL . 0.4 OUTLIER -55.03 -50.23 69.6 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.317 -0.864 . . . . 0.0 111.482 177.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.726 ' HB2' ' CH2' ' A' ' 84' ' ' TRP . . . -62.73 -37.67 87.45 Favored 'General case' 0 CA--C 1.548 0.889 0 O-C-N 121.76 -0.587 . . . . 0.0 112.031 174.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 22.4 tp -53.98 -43.84 70.31 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.806 1.242 . . . . 0.0 111.998 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 126' ' ' TYR . 1.8 mp -73.28 -48.87 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 O-C-N 121.135 -0.978 . . . . 0.0 110.378 176.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.4 ' HG3' HD21 ' A' ' 85' ' ' LEU . 65.4 mm-40 -62.58 -21.6 65.73 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -176.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.2 p -71.1 -17.28 62.59 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 169.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.07 -6.38 3.7 Favored Glycine 0 CA--C 1.541 1.704 0 C-N-CA 126.85 2.167 . . . . 0.0 116.102 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' MET . . . . . . . . . . . . . 17.5 tpp -71.29 166.59 21.26 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.821 1.811 . . . . 0.0 112.627 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.12 135.65 45.22 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 126.422 1.889 . . . . 0.0 107.405 169.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.45 ' HA ' HD11 ' A' ' 120' ' ' ILE . 3.7 p90 -58.81 -33.82 70.81 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 113.466 0.913 . . . . 0.0 113.466 -172.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -58.05 -35.98 72.1 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.261 1.424 . . . . 0.0 113.084 175.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -74.86 -45.68 41.39 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.499 1.12 . . . . 0.0 111.14 170.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -54.76 -33.64 61.56 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.939 1.296 . . . . 0.0 113.559 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . . . . . . . . . 11.5 mm -51.48 -55.99 6.77 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-N 119.479 1.036 . . . . 0.0 110.043 173.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -61.62 -17.45 55.31 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.313 1.445 . . . . 0.0 112.802 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -85.74 -51.94 6.1 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.985 1.714 . . . . 0.0 112.565 174.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ILE . . . . . 0.614 HD13 ' HB2' ' A' ' 116' ' ' ALA . 2.0 pt -84.85 -44.23 17.38 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -178.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.64 -14.14 7.58 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 126.448 1.899 . . . . 0.0 112.987 175.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 2.6 pp0? -53.87 -18.57 3.45 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.307 1.443 . . . . 0.0 114.37 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.62 -16.83 63.97 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.428 1.491 . . . . 0.0 113.146 172.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 26.2 ttt180 100.92 104.0 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.122 1 C-N-CA 132.804 4.442 . . . . 0.0 110.115 173.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 16.6 mtp180 59.87 -170.85 0.13 Allowed 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 127.106 2.162 . . . . 0.0 112.546 -172.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 92.08 2.3 68.94 Favored Glycine 0 CA--C 1.534 1.268 0 N-CA-C 116.124 1.21 . . . . 0.0 116.124 177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -146.07 52.14 1.15 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.921 1.288 . . . . 0.0 112.383 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 7.2 tt -142.08 16.91 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.973 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 -172.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.27 172.68 6.63 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 124.786 1.234 . . . . 0.0 112.906 173.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 40.3 t -73.63 -89.06 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 124.233 1.013 . . . . 0.0 112.278 177.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -56.49 -23.82 41.86 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 125.703 1.601 . . . . 0.0 114.409 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -53.72 -47.95 70.06 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.14 1.776 . . . . 0.0 112.798 169.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -106.44 -33.82 7.6 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 119.239 0.927 . . . . 0.0 113.399 -173.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' THR . . . . . . . . . . . . . 69.6 p -65.06 -3.74 3.98 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 173.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -53.41 -40.08 64.82 Favored 'General case' 0 CA--C 1.552 1.04 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -178.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.7 tp -58.34 -32.47 68.55 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.121 1.768 . . . . 0.0 113.023 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -60.63 -11.44 7.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.324 1.45 . . . . 0.0 112.248 176.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -121.63 -33.93 3.51 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.552 2.341 . . . . 0.0 113.667 170.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TYR . . . . . . . . . . . . . 27.4 t80 -99.08 116.75 32.01 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.48 1.512 . . . . 0.0 113.753 -177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ARG . . . . . . . . . . . . . 4.8 ttt85 -69.95 129.14 91.21 Favored Pre-proline 0 N--CA 1.477 0.898 0 C-N-CA 124.431 1.093 . . . . 0.0 112.784 -178.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.06 3.18 3.57 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 123.786 2.99 . . . . 0.0 114.708 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -106.87 160.07 15.78 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.431 1.492 . . . . 0.0 111.522 174.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 87.39 12.05 0.12 Allowed 'General case' 0 N--CA 1.483 1.183 0 C-N-CA 129.031 2.932 . . . . 0.0 113.691 177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -121.25 -92.6 0.54 Allowed 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.2 1.4 . . . . 0.0 111.786 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 52.6 mt -87.25 47.45 1.5 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 124.217 1.007 . . . . 0.0 112.609 -173.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 51.5 ttt85 -131.34 -76.8 0.52 Allowed 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 126.503 1.921 . . . . 0.0 111.288 178.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -147.54 99.92 3.18 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.441 1.496 . . . . 0.0 110.489 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -147.95 -42.59 0.16 Allowed 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 124.854 1.262 . . . . 0.0 113.33 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 4.6 t70 . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.313 1.845 . . . . 0.0 113.345 -170.484 . . . . . . . . 0 0 . 1 stop_ save_